Norris Medicines has informed that as per company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders framed pursuant to the Security and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015, the Trading Window for dealing in the Securities of the Company will be closed for the Financial year ended on declaration of Unaudited Financial Results of the Company for the Quarter ended on September, 30th 2018 for all the designated persons (Including Promotes and Directors) of the Company from 1st November, 2018 till 48 hours of working days after the announcement of the Unaudited Financial Results of the Company to the Stock Exchanges i.e. till 15th November, 2018. The Trading Window shall re-open with effect from 16st November, 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: